ZN PHARMACEUTICALS LTD

Company Registration Number:
14638866 (England and Wales)

Unaudited statutory accounts for the year ended 28 February 2024

(Dormant)

Period of accounts

Start date: 03 February 2023

End date: 28 February 2024

ZN PHARMACEUTICALS LTD

Contents of the Financial Statements

for the Period Ended 28 February 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8

ZN PHARMACEUTICALS LTD

Company Information

for the Period Ended 28 February 2024




Director: Zarrar Nasir
Registered office: 1
Astley Road
Manchester
England
M13 9EH
Company Registration Number: 14638866 (England and Wales)

ZN PHARMACEUTICALS LTD

Directors' Report Period Ended 28 February 2024

The directors present their report with the financial statements of the company for the period ended 28 February 2024

Directors

The director(s) shown below were appointed to the company during the period
Zarrar Nasir
03 February 2023

The company was dormant and did not trade in the period.

This report was approved by the board of directors on 20 November 2024
And Signed On Behalf Of The Board By:

Name: Zarrar Nasir
Status: Director

ZN PHARMACEUTICALS LTD

Profit and Loss Account

for the Period Ended 28 February 2024

The company was dormant and did not trade in the period. The company received no income and incurred no expenditure in the period and therefore did not make either a profit or loss.

ZN PHARMACEUTICALS LTD

Balance sheet

As at 28 February 2024


Notes
13 months to
28 Feb 2024
£
Fixed assets
Total fixed assets: -
Current assets
Stocks: 1
Total current assets: 1
Net current assets (liabilities): 1
Total assets less current liabilities: 1
Total net assets (liabilities): 1

The notes form part of these financial statements

ZN PHARMACEUTICALS LTD

Balance sheet continued

As at 28 February 2024


Notes
13 months to
28 Feb 2024
£
Capital and reserves
Called up share capital: 1
Shareholders funds: 1

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

For the year ending 28 February 2024 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.

This report was approved by the board of directors on 20 November 2024
And Signed On Behalf Of The Board By:

Name: Zarrar Nasir
Status: Director

The notes form part of these financial statements

ZN PHARMACEUTICALS LTD

Notes to the Financial Statements

for the Period Ended 28 February 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    Company is dormant and has never traded

ZN PHARMACEUTICALS LTD

Notes to the Financial Statements

for the Period Ended 28 February 2024

  • 2. Employees

    13 months to
    28 Feb 2024
    Average number of employees during the period 2

ZN PHARMACEUTICALS LTD

Notes to the Financial Statements

for the Period Ended 28 February 2024

  • 3. Off balance sheet disclosure

    No